Page last updated: 2024-11-07

azauridine and Leukemia, Myeloid, Acute

azauridine has been researched along with Leukemia, Myeloid, Acute in 2 studies

Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grignani, F1
Martelli, M1
Tonato, M1
Fleming, I1
Simone, J1
Jackson, R1
Johnson, W1
Walters, T1
Mason, C1

Other Studies

2 other studies available for azauridine and Leukemia, Myeloid, Acute

ArticleYear
[Antimetabolites in the treatment of acute human leukoses. Mechanism of action and conditioning factors in the cellular response to drugs. II].
    La Clinica terapeutica, 1974, Apr-30, Volume: 69, Issue:2

    Topics: Antimetabolites; Azacitidine; Azaguanine; Azauridine; Cell Membrane Permeability; Cytarabine; DNA, N

1974
Proceedings: Splenectomy and chemotherapy in acute myelocytic leukemia of childhood.
    Cancer, 1974, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Age Factors; Azauridine; Child; Child, Preschool; Cytarabine; Drug Therapy, Combi

1974